Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study

The Lancet Oncology (2011) - Comments
doi: 10.1016/s1470-2045(11)70119-x issn: 1470-2045 pubmed: 21601526

Anita Villani, Uri Tabori, Joshua Schiffman, Adam Shlien, Joseph Beyene, Harriet Druker, Ana Novokmet, Jonathan Finlay, David Malkin